IMPACT OF METASTASECTOMY ON PROGNOSIS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA IN THE TARGETED THERAPY ERA

被引：2
|
作者：
You, Dalsan
Lee, Chunwoo
Jeong, In Gab
Song, Sang Hoon
Kim, Kun Suk
Song, Cheryn
Lee, Jae-Lyun
Hong, Bumsik
Ahn, Hanjong
Kim, Choung-Soo
机构：
来源：
JOURNAL OF UROLOGY | 2015年 / 193卷 / 04期
关键词：
D O I：
10.1016/j.juro.2015.02.2517
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP69-13
引用
收藏
页码：E871 / E872
页数：2
相关论文
共 50 条
  • [31] The impact of facility case volume on overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era.
    Chen, Yu-Wei
    Tullio, Katherine
    Ornstein, Moshe Chaim
    Grivas, Petros
    Garcia, Jorge A.
    Rini, Brian I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [32] Outcomes of patients with metastatic renal cell carcinoma and bone metastases in the targeted-therapy era
    Kalra, Sarathi
    Verma, Jonathan
    Atkinson, Bradley J.
    Matin, Surena F.
    Wood, Christopher G.
    Karam, Jose A.
    Tamboli, Pheroze
    Sircar, Kanishka
    Rao, Priya
    Corn, Paul Gettys
    Tannir, Nizar M.
    Jonasch, Eric
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [33] Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review
    Rodriguez Faba, Oscar
    Brookman-May, Sabine D.
    Linares, Estefania
    Breda, Alberto
    Pisano, Francesca
    Daniel Subiela, Jose
    Sanguedolce, Francesco
    Brausi, Maurizio
    Palou, Joan
    [J]. WORLD JOURNAL OF UROLOGY, 2017, 35 (12) : 1807 - 1816
  • [34] Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review
    Oscar Rodriguez Faba
    Sabine D. Brookman-May
    Estefania Linares
    Alberto Breda
    Francesca Pisano
    José Daniel Subiela
    Francesco Sanguedolce
    Maurizio Brausi
    Joan Palou
    [J]. World Journal of Urology, 2017, 35 : 1807 - 1816
  • [35] The Value of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy
    You, Dalsan
    Jeong, In Gab
    Ahn, Jin-Hee
    Lee, Dae Ho
    Lee, Jae-Lyun
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    [J]. JOURNAL OF UROLOGY, 2011, 185 (01): : 54 - 59
  • [36] Treatment of metastatic renal cell carcinoma: immunotherapy in the era of molecular targeted therapy
    Naito, Seiji
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2010, 17 : A6 - A7
  • [37] Outcome of treatment discontinuation in patients with metastatic renal cell carcinoma and no evidence of disease following targeted therapy with or without metastasectomy
    Johannsen, M.
    Staehler, M.
    Ohlmann, C. -H.
    Floercken, A.
    Schmittel, A.
    Otto, T.
    Bex, A.
    Hein, P.
    Miller, K.
    Weikert, S.
    Guenwald, V.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (03) : 657 - 663
  • [38] Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy
    Kawano, Yoshiaki
    Takahashi, Wataru
    Eto, Masatoshi
    Kamba, Tomomi
    Miyake, Hideaki
    Fujisawa, Masato
    Kamai, Takao
    Uemura, Hirotsugu
    Tsukamoto, Taiji
    Azuma, Haruhito
    Matsubara, Akio
    Nishimura, Kazuo
    Nakamura, Tsuyoshi
    Ogawa, Osamu
    Naito, Seiji
    [J]. CANCER SCIENCE, 2016, 107 (07) : 1013 - 1017
  • [39] Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma
    Eggener, Scott E.
    Yossepowitch, Ofer
    Kundu, Shilajit
    Motzer, Robert J.
    Russo, Paul
    [J]. JOURNAL OF UROLOGY, 2008, 180 (03): : 873 - 878
  • [40] Targeted therapy for metastatic renal cell carcinoma
    Motzer, Robert J.
    Bukowski, Ronald M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (35) : 5601 - 5608
12345